Refresh

Corona Remedies Ltd.

Corona Remedies Ltd. is not listed on BSE

© 2025 Rediff.com
Corona Remedies Ltd. is not listed on NSE

© 2025 Rediff.com

News for Corona Remedies Ltd.

Corona Remedies IPO Subscribed 9.33 Times
Corona Remedies'' Rs 655-cr IPO subscribed 9.33 times on day 2. IPO details, subscription status, and company overview.
Dec 09, 2025 19:34
Corona Remedies IPO Subscribed 62% on Day 1
Corona Remedies'' Rs 655-cr IPO received 62% subscription on day 1. Details on retail, non-institutional investor response and more.
Dec 08, 2025 20:30
Corona Remedies Raises ₹195 Cr from Anchor Investors
Corona Remedies raises ₹195 cr from anchor investors before IPO. Public offering opens Dec 8. Find details on share allocation and company growth.
Dec 05, 2025 22:04
Corona Remedies IPO Opens Dec 8 | Price Band & Details
Corona Remedies IPO opens December 8 with price band Rs 1,008-1,062/share. Details on OFS, dates, and company profile.
Dec 03, 2025 10:49
IPO Pipeline Swells: Rs 40,000 Cr Public Offers
2 Dozen companies line up IPOs to raise Rs 40,000 Cr in Dec-Jan. ICICI Prudential AMC, Meesho, Juniper Green Energy lead the way.
Nov 30, 2025 10:35

More News for Corona Remedies Ltd. »

News for Pharmaceuticals and health care

Tata Steel to Acquire Stake in Thriveni Pellets
Tata Steel signs agreement to acquire majority stake in Thriveni Pellets. Acquisition to bolster raw material supply chain.
Dec 10, 2025 18:01
Fertiliser Industry Seeks Subsidy Reforms, GST Relief
Fertiliser industry urges subsidy reforms, GST relief, NBS extension to urea, and ITC resolution to boost sector viability.
Dec 10, 2025 18:01
CredFlow Gets NBFC Licence from RBI
CredFlow receives NBFC licence from RBI for SME lending. CashFloat operates under Cashpositive Finance. Data-native NBFC for working capital.
Dec 10, 2025 17:13
BSE Launches New Large-Cap Factor Indices
BSE Index Services launches four new large-cap factor indices: momentum, low volatility, value, and quality. Track market strategies.
Dec 10, 2025 17:09
Servier India Gets CDSCO Nod for Brain Cancer Drug
Servier India receives CDSCO approval for Vorasidenib (Voranigo), a brain cancer drug for Grade 2 IDH-mutant glioma patients.
Dec 10, 2025 17:07

More News »

Top News

CG Power Turnaround: Srinivasan's Book
N Srinivasan's book chronicles CG Power's revival from bankruptcy to a USD 10 billion company. Learn about the corporate turnaround.
Dec 10, 2025 18:03
Tata Steel to Acquire Stake in Thriveni Pellets
Tata Steel signs agreement to acquire majority stake in Thriveni Pellets. Acquisition to bolster raw material supply chain.
Dec 10, 2025 18:01
Fertiliser Industry Seeks Subsidy Reforms, GST Relief
Fertiliser industry urges subsidy reforms, GST relief, NBS extension to urea, and ITC resolution to boost sector viability.
Dec 10, 2025 18:01
Rangsons Aerospace Wins Airbus Award
Rangsons Aerospace secures long-term award with Airbus to manufacture aviation tubes for the A320 Family. Key partnership for Indian aerospace.
Dec 10, 2025 17:48
IndiGo Crisis: DGCA Oversight Team Set Up
DGCA forms 8-member oversight team for IndiGo after flight cancellations due to crew shortage. Two members to be at IndiGo HQ daily.
Dec 10, 2025 17:38

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com